Abstract: The invention relates to a pharmaceutical formulation, e.g. a paediatric formulation, of odevixibat, which comprises a plurality of small particles. The formulation may be used in the treatment of liver diseases such as bile acid-dependent liver diseases, and particularly cholestatic liver diseases such as biliary atresia, progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome (ALGS) and paediatric cholestatic pruritus. The invention also relates to a process for the preparation of the pharmaceutical formulation.

Abstract: The invention relates to a pharmaceutical formulation, e.g. a paediatric formulation, of odevixibat, which comprises a plurality of small particles. The formulation may be used in the treatment of liver diseases such as bile acid-dependent liver diseases, and particularly cholestatic liver diseases such as biliary atresia, progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome (ALGS) and paediatric cholestatic pruritus. The invention also relates to a process for the preparation of the pharmaceutical formulation.

Abstract: The present invention teaches a method, system, terminals and service node for geographically positioning a first mobile radio terminal (MS1) within a radio network (100) comprising unsynchronised radio base stations by using a plurality of second fixed radio terminals (MS2) whereby the positions of the radio base stations and the second fixed radio terminals are known. First and second radio terminals (MS1,MS2) measure the relative receive times between the timing signals downlink (113-118) received from at least three radio base stations (BS1,BS2,BS3) and the second fixed radio terminals (MS2)send them to a service node (107) in the network (100) using them for calculating the transmission time offsets of the timing signals downlink.